References
- Nightingale SL. BCG live approved for carcinoma in situ of the urinary bladder. JAMA 1990; 264: 677
- Organon's Tice BCG vaccine approved for bladder cancer. 1990; 24, Scrip No. 1560
- Crispen RG. BCG and cancer. Dev Biol Standard 1986; 58: 371–377
- Bartlett GL., Zbar B, Rapp HJ. Suppression of murine tumor growth by immune reaction to the bacillus Calmette-Guérin strain of Mycobacterium bovis. J Natl Cancer Inst 1972; 48: 245–257
- Embleton MJ. Effect of BCG on cell-mediated cytotoxicity and serum blocking factor during growth of rat hepatoma. Br J Cancer 1976; 33: 584–592
- Klegerman ME., Ujjainwala L, Zeunert P. High-dose inhibition and low-dose enhancement of murine sarcoma growth exhibited by BCG vaccine. Cancer Lett 1991; 56: 137–145
- McGarrity GJ. Detection of mycoplasmal infection of cell cultures. Adv Cell Culture 1982; 2: 99–131
- Olson WP., Groves MJ., Klegerman ME. Cell mass of Mycobacterium bovis BCG estimated by gas chromatography. Biologicals 1990; 18: 83–88
- Watson LP., McKee AE., Merrell BR. Preparation of microbiological specimens for scanning electron microscopy. Scan Electron Microsc Pt 1980; 2: 45–56
- Baldwin RW., Pimm MV. BCG immunotherapy of pulmomary growths from intravenously transferred rat tumour cells. Br J Cancer 1973; 27: 48–54
- Sparks FC., Breeding JH. Tumor regression and enhancement resulting from immunotherapy with bacillus Calmette-Guérin and neuraminidase. Cancer Res 1974; 34: 3262–3269
- Alexander P. Activated macrophages and the antitumor action of BCG. Natl Cancer Inst Monogr 1973; 38: 127–133
- Davies M, Sabbadini E. Effect of BCG on alloimmune cell-mediated cytotoxicity in (C57BL/6Jo × A/Jo)F1 mice. II. Correlation with BCG activity in syngeneic tumor systems. J Natl Cancer Inst 1978; 60: 1069–1073
- Fidler IJ. Macrophages and metastasis—A biological approach to cancer therapy: Presidential address. Cancer Res 1985; 45: 4714–4722
- Hawrylko E. BCG immunopotentiation of an antitumor response: Evidence for a cell-mediated mechanism. J Natl Cancer Inst 1975; 55: 413–423
- Ratliff TL., McGarr JA., Abou-Zeid C, et al. Attachment of my-cobacteria to fibronectin-coated surfaces. J Gen Microbiol 1988; 134: 1307–1313
- Hudson MA., Ritchey JK., Catalona WJ., et al. Comparison of the fibronectin-binding ability and antitumor efficacy of various my-cobacteria. Cancer Res 1990; 50: 3843–3847
- Kavoussi LR., Brown EJ., Ritchey JK., et al. Fibronectin-mediated Calmette-Guérin bacillus attachment to murine bladder mucosa: Requirement for the expression of an antitumor response. J Clin Invest 1990; 85: 62–67
- Klegerman ME., Zeunert PL., Lajeune J, et al. Relative tumor inhibitory and stimulatory activities of BCG vaccine preparations, lots and substrains in a quantitative mouse sarcoma bioassay. Anticancer Res 1991; 11: 1707–1710